Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ala. settles suits with 6 drug firms for $89M
Yahoo/AP
Saturday, May 23, 2009 - 9:43am
tags:
Cell Genesys Commences Exchange Offer for $68.3 million Convertible Notes
Yahoo
Saturday, May 23, 2009 - 9:42am
tags:
Cell Genesys
Law Office of Brodsky & Smith, LLC Announces Investigation on Behalf of Shareholders of Cougar Biotechnology, Inc.
Yahoo
Saturday, May 23, 2009 - 9:37am
tags:
Cougar Biotechnology
[video]Mad About Options: Amgen Flashback
TheStreet.com
Friday, May 22, 2009 - 11:17am
tags:
Amgen, options
Dr. Reddy's will start separate brand-name research unit and restructure discovery operations
Yahoo/AP
Friday, May 22, 2009 - 11:15am
tags:
Dr Reddy's, restructuring
J&J Just Made Medivation's Day
TheStreet.com
Friday, May 22, 2009 - 11:14am
tags:
JNJ, buyouts, Cougar Biotechnology, Medivation
Aastrom puts mid stage trial of stem cells on hold after patient died for unknown reasons
Yahoo/AP
Friday, May 22, 2009 - 11:13am
tags:
Aastrom, drug trials
FDA, Clinical Trial Updates: Genzyme, Human Genome Sciences, Eli Lilly, NeurogesX
Seeking Alpha
Friday, May 22, 2009 - 11:12am
tags:
FDA, Eli Lilly, Genzyme, drug trials, Human Genome Sciences, NeurogesX
Gilead Sciences: Stock in Decline or Great Buying Opportunity?
Seeking Alpha
Friday, May 22, 2009 - 10:05am
tags:
Gilead Sciences
Vanda Holding Up Well
Seeking Alpha
Friday, May 22, 2009 - 10:04am
tags:
Vanda, Fanapt
Merck, CIGNA Prove It Pays to Be Healthy
Seeking Alpha
Friday, May 22, 2009 - 10:02am
tags:
Merck, Cigna, diabetes
If You Can't Beat 'Em, Join 'Em: Pharma Goes Generic
Motley Fool
Friday, May 22, 2009 - 7:29am
tags:
Big Pharma, generics, Teva Pharmaceuticals, Perrigo Company, Mylan, Watson Pharmaceuticals, Novartis, GSK, Pfizer, Sanofi
The AstraZeneca Dilemma
Motley Fool
Friday, May 22, 2009 - 7:28am
tags:
AstraZeneca, M&A, patents
Jury Still Out On Isis Cholesterol Drug
Forbes
Friday, May 22, 2009 - 7:26am
tags:
Isis Pharmaceuticals, cholesterol, mipomersen, Genzyme
Johnson & Johnson Seeks Cancer Medicines in Cougar Acquisition
Bloomberg
Friday, May 22, 2009 - 7:25am
tags:
JNJ, buyouts, Cougar Biotechnology
Antibiotic’s $1 Billion Success May Spur Cubist Acquisition
Bloomberg
Friday, May 22, 2009 - 7:24am
tags:
Cubist Pharmaceuticals, M&A, antibiotics, Cubicin
Glaxo may have $1.9 billion showdown with IRS: WSJ
Marketwatch
Thursday, May 21, 2009 - 6:34pm
tags:
IRS, taxes, GSK
Not So Fast, Schering ... er, Merck ... er, Whoever You Are
Motley Fool
Thursday, May 21, 2009 - 6:33pm
tags:
Merck, Schering Plough, JNJ, Remicade
GlaxoSmithKline shareholders back executive pay reforms
Guardian,UK
Thursday, May 21, 2009 - 3:24pm
tags:
GSK, Pharma CEOs
Stem Cell Stocks Mixed on Heavy Volume Action
Yahoo/Indie Research
Thursday, May 21, 2009 - 3:21pm
tags:
stem cells, Neuralstem, Cytori, Aastrom

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.